Statistics Guide for Research Grant Applicants
Checklist
This checklist can be downloaded as an Adobe Acrobat PDF
file, for ease of printing.
Tick [ ] those that apply
Design
- Is the study observational? [ ]
(see A-1.1 and A-1.2)
- If Yes
- Is it a cohort study? [ ]
(see A-1.3)
- Is it a case-control study? [ ]
(see A-1.4)
- Is it a cross-sectional study? [ ]
(see A-1.5)
- If Yes to cross-sectional study
- Is it a prevalence study? [ ]
(see A-1.5a)
- Is it estimating sensitivity and specificity? [
]
(see A-1.5b and A-1.5c)
- Is it an ecological study? [ ]
(see A-1.5d)
- Have you addressed the issue of confounding in your proposal?
[ ]
(see A-1.6)
- Is the study experimental? [ ]
(see A-1.1, A-1.2)
- If Yes
- Is the study a type of trial e.g. a clinical trial? [
]
(see A-1.7, A-1.8)
- If Yes
- Is the study a controlled trial (i.e. is there a
control group)? [ ]
(see A-1.8 and B-3)
- Is it a randomised trial
(i.e. are study subjects randomly allocated to groups)? [
]
(see A-1.8 and B-5)
- If Yes to randomised trial
- Is it important to have similar numbers in each
randomisation group? (you may need to use blocks) [
]
(see B-5.6)
- Are any known factors strongly prognostic? [
]
(you may need to randomise in strata)
(see B-5.7)
- If Yes to strongly prognostic factors
- Is the proposed sample size small? [ ]
(see B-5.8)
- Are groups of individuals to be randomised together
to the same treatment? [ ]
(see B-5.9)
- Is this a cross over trial? [ ]
(see B-5.10b)
- Is the assessor blind? [ ]
(see A-1.8 and B-4)
- Are the study subjects blind? [ ]
(see A-1.8 and B-4)
- Is the study prospective? [ ]
(see A-2)
- If Yes
- Have you specified the length of follow up? [ ]
(see A-2)
The Study Subjects
(see A-3)
- Have you described where they come from? [ ]
- Have you explained why they are an appropriate group? [ ]
- Have you described how the study subjects will be selected? [
]
- Have you specified inclusion / exclusion criteria? [ ]
- Have you specified your proposed sample size taking into account
refusals/drop-outs? [ ]
Types of Variables
(see A-4)
- Have you described all outcome and explanatory variables in
terms of data type and scale of measurement? [ ]
(see A-4.1 and A-4.2)
- Have you described how the data will be collected? [ ]
(see A-4.3)
- If using a questionnaire or a non-standard measurement, have
you provided information on its reliability and validity? [
]
(see A-4.4, A-4.4a, A-4.4b, A-4.4c)
Sample Size
- Have you provided a sample size calculation? [ ]
(see D-1)
- Have you defined the outcome variable(s) used in the sample
size calculation? [ ]
(see D-5)
- Have you defined the effect size which would be of clinical
importance? [ ]
(see D-4.5)
- Have you described the power and significance level of the sample
size calculation? [ ]
(see D-4.3 and D-4.4)
- Has your sample size made allowance for expected response rates
and other sample attrition? [ ]
(see D-6)
- Is your sample size consistent with the study aims? [ ]
(see D-7)
- Is your sample size consistent with the proposed analysis of the
study? [ ]
(see D-7)
- Is your description of the sample size calculation adequate? [
]
(See examples in D-8)
Statistical Analysis
- Have you described the proposed statistical methods using
appropriate terminology? [ ]
(see E-1.1, E-1.2)
- Are the proposed methods appropriate for the types of data generated
by your study? [ ]
(see E-2, E-2.1, E-11)
- Will the assumptions made by the proposed methods hold? [
]
(see E-4, E-4.1)
- Do the proposed methods take account of the structure of the data
set (structure such as hierarchy, clustering, matching, paired
data)? [ ]
(see E-3, E-6, E-6.2, E-10)
- Have important confounding factors been listed and methods of
adjusting for them presented? [ ]
(see E-5)
- Will the proposed methods take account of multiple testing
where appropriate? [ ]
(see E-7.1, E-7.2, E-7.3, E-7.4, E-7.4a, E-7.4b, E-7.4c,
E-7.4d, E-7.4e, E-7.4f)
- Have biases due to measurement error been considered e.g.
regression towards the mean? [ ]
(see E-8)
- Have details on the calculation of confidence intervals been
provided? [ ]
(see E-12)
For clinical trials only
- Have you specified that your analysis will be by intention to
treat? [ ]
(see E-9)
Back to Brief Table of Contents.
Back to Martin Bland's home page.
This page is maintained by Martin Bland.
Last updated: 10 September, 2009.
Back to top